Skip to content
  • LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn
  • Landscape

Ricky Solorzano

  • Pluristyx Is Building the Manufacturing Layer Behind Biofabricated Liver Therapies
    August 18, 2026

    Pluristyx Is Building the Manufacturing Layer Behind Biofabricated Liver Therapies

    Ricky Solorzano
  • Tides Medical’s APLICOR 3D Used for World’s First 3D-Printed Breast Fat Graft
    August 13, 2026

    Tides Medical’s APLICOR 3D Used for World’s First 3D-Printed Breast Fat Graft

    Ricky Solorzano
  • Bruker Just Bought Control of MIMETAS, and With It, a Seat at the Center of the NAMs Transition
    August 12, 2026

    Bruker Just Bought Control of MIMETAS, and With It, a Seat at the Center of the NAMs Transition

    Ricky Solorzano
  • Humacyte Advances Bioengineered Coronary Vessel Into First Human Study
    August 11, 2026

    Humacyte Advances Bioengineered Coronary Vessel Into First Human Study

    Ricky Solorzano
  • Paragonix’s KidneyVault Pushes Organ Preservation Beyond Geographic Limits
    August 7, 2026

    Paragonix’s KidneyVault Pushes Organ Preservation Beyond Geographic Limits

    Ricky Solorzano
  • Europe’s New Bioprinting Cluster Signals a Shift From Printing Tissues to Building Therapies
    July 21, 2026

    Europe’s New Bioprinting Cluster Signals a Shift From Printing Tissues to Building Therapies

    Ricky Solorzano
  • Auxilium Bioprints Kidney and Liver Tissue in Orbit—and Tests a Multi-Product Manufacturing Model
    July 20, 2026

    Auxilium Bioprints Kidney and Liver Tissue in Orbit—and Tests a Multi-Product Manufacturing Model

    Ricky Solorzano
  • Vivodyne Is Trying to Industrialize Human Tissue Testing
    July 19, 2026

    Vivodyne Is Trying to Industrialize Human Tissue Testing

    Ricky Solorzano
  • STEMCELL Technologies and CCRM Build a Matched iPSC Path from Research to GMP
    July 13, 2026

    STEMCELL Technologies and CCRM Build a Matched iPSC Path from Research to GMP

    Ricky Solorzano
  • United Therapeutics Buys Thymmune: Why the Thymus May Become Critical Infrastructure for Organ Manufacturing
    July 7, 2026

    United Therapeutics Buys Thymmune: Why the Thymus May Become Critical Infrastructure for Organ Manufacturing

    Ricky Solorzano
1 2 3 … 16
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    • The Business of Biofabrication
    • Already have a WordPress.com account? Log in now.
    • The Business of Biofabrication
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar